MHRA
- Status: approved
Riltozinameran 12 Years of age and older (riltozinameran-12-years-of-age-and-older) regulatory status in United Kingdom.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MHRA has authorised it.
Pfizer is the originator. The local marketing authorisation holder may differ — check the official source linked above.